Monthly Archives: March 2019

Esketamine

The FDA recently approved Esketamine, a medication which is available from Janssen Neuroscience under the brand name Spravato. Spravato is available only through a restricted program known as the Spravato REMS (Risk Evaluation and Mitigation Strategy) because of serious adverse outcomes that can be associated with the use of the medication including sedation, dissociation, abuse,…